ABOUT US
Home / About Us
Ubisson Sdn. Bhd., a subsidiary of RX Pharma Sdn. Bhd., incorporated in 2006, works with global renown innovators to import, market and distribute innovative pharmaceutical & healthcare products to clinics, hospitals, pharmacies and various healthcare institutions, both in the private and public sectors.
In this environment of ever faster increasing pace of medical & pharmaceutical technology advancement, our mission to launch innovative healthcare solutions in this region is becoming more imperative than ever.
As our name dictates, UBISSON 優必勝 (Winning By Excellence) will continue to strive for excellence in providing dedicated services to our stakeholders in promoting Innovative Healthcare Solutions for a Better Life.
The only British/European and US Pharmacopoeia grade activated charcoal registered with National Pharmaceutical Regulatory Authority (NPRA, Malaysia): MAL06121041XZ
The only British/European and US Pharmacopoeia grade activated charcoal registered with National Pharmaceutical Regulatory Authority (NPRA, Malaysia): MAL07061673XZ
Artesun™ (Artesunate Injection 60mg) listed in Malaysian Ministry of Health (MOH) Medication Formulary (FUKKM: P01BE03-000-P30-01-XXX-B) for treatment of severe malaria in adults and children.
Heberprot-P® Exclusive Distribution Agreement for Malaysia, Singapore and Brunei signed between Ubisson Sdn. Bhd. represented by CEO Mr. Peter Ting Yiik Pung and Cuban Institute for Genetic Engineering and Biotechnology (CIGB) witnessed by Her Excellency Cuban Ambassador to Malaysia, Ibete Fernandez Hernandez and Secretary General for Malaysian Ministry of International Trade and Industry, YBhg Dato’ Lokman Hakim bin Ali, Vice President of Diabetes Malaysia, Mr. Jong Koi Chong, and President of Malaysia-Cuba Friendship Association, Mr. Fahmy Kai.
Swinburne University of Technology (Sarawak Campus) signed an inaugural agreement with Ubisson Sdn. Bhd. to develop a digital platform named BioTective™ with mobile apps and cloud-based online application for chronic disease monitoring and management.
Swinburne University of Technology (Sarawak Campus) and Ubisson Sdn. Bhd. launched BioTective™ platform for online chronic disease monitoring and management.